NABRIVA THERAPEUTICS PLC - SHS Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2017 to Q3 2022

Type / Class
Equity / SHS
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of NABRIVA THERAPEUTICS PLC - SHS across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q3 0 $0 -$1,000 0
2022 Q2 3,000 $1,000 -$667 $0.33 1
2022 Q1 5,000 $2,000 $0.40 1
2021 Q4 5,000 $3,000 $0.60 1
2021 Q3 5,000 $6,000 $1.20 1
2021 Q2 5,000 $7,000 $1.40 1
2021 Q1 5,000 $8,000 -$462,000 $1.60 1
2020 Q4 196,028 $474,000 -$19,545,506 $2.41 2
2020 Q3 30,701,203 $16,361,489 -$1,126,893 $0.53 46
2020 Q2 32,043,383 $21,614,931 +$5,215,610 $0.67 50
2020 Q1 23,263,283 $14,312,893 -$5,863,612 $0.57 48
2019 Q4 28,202,844 $37,233,960 +$5,447,973 $1.32 47
2019 Q3 23,276,571 $46,558,000 -$13,958,785 $2.00 43
2019 Q2 28,540,905 $69,140,675 -$1,519,444 $2.43 39
2019 Q1 29,149,277 $71,092,686 -$3,312,033 $2.44 40
2018 Q4 32,211,835 $47,030,607 -$3,467,928 $1.46 47
2018 Q3 31,881,875 $85,948,700 +$27,084,497 $2.70 45
2018 Q2 21,066,343 $73,307,480 -$18,120,072 $3.48 42
2018 Q1 25,291,213 $127,212,030 +$13,609,043 $5.03 45
2017 Q4 22,519,364 $134,664,980 -$9,566,633 $5.98 45
2017 Q3 21,061,325 $172,371,190 +$65,273,296 $8.19 41
2017 Q2 12,602,491 $134,287,000 +$134,117,000 $10.48 20